RT Journal Article
SR Electronic
T1 Use of consensus term and definition for delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19007260
DO 10.1101/19007260
A1 Matthew J Rowland
A1 Kyle T.S. Pattinson
A1 Mervyn D.I. Vergouwen
A1 Peter J Watkinson
YR 2019
UL http://medrxiv.org/content/early/2019/09/23/19007260.abstract
AB Background and purpose In 2010, a multidisciplinary research group proposed a consensus term and definition for the complication of delayed cerebral ischaemia (DCI) following aneurysmal subarachnoid haemorrhage (SAH). We assessed the use of this term and its definition as an endpoint in observational studies and clinical trials.Methods Firstly, we performed a MEDLINE abstract search from Jan 2008 to Dec 2017 for observational cohort studies and clinical trials to investigate the used terminology over the years. Next, we studied trends in citations of the original paper citing the consensus definitions since publication in 2010.Results The number of publications citing the 2010 consensus definitions has steadily increased from 18 in 2011 to 54 in 2017. Between 2010 and 2017, 527 papers were published with delayed cerebral ischemia, or another term to describe the same complication, as an endpoint. However, the term delayed cerebral ischemia was used only in 131/527 (25%) of papers and only 14/81 (17%) of clinical trials/cohort studies published in 2017 cited the consensus definitions when outlining study endpoints.Conclusions Despite publication of consensus terminology and definitions for DCI in 2010, the majority of cohort studies and clinical trials in patients with SAH are not using these. Researchers and editors should be reminded of the importance of using these consensus terminology and definitions in future studies, which will promote the comparability of results between studies, understand the true impact of an intervention, aggregate results in meta-analyses, and construct guidelines with a high level of evidence.Competing Interest StatementKP and MR are named as coinventors on a provisional U.K. patent application titled “Use of cerebral nitric oxide donors in the assessment of the extent of brain dysfunction following injury.Clinical TrialThis is a retrospective study and not a clinical trial.Funding StatementNo external funding was received for this work. KTSP and PJW are supported by the National Institute for Health Research Biomedical Research Centre based at Oxford University Hospitals NHS Trust and The University of Oxford.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not Applicablenot applicable